Linagliptin Tablets 5MG – Laglin 5 Tablets

Laglin 5 Tablets – DPP-4 Inhibition with Consistent Glycemic Precision.

Laglin 5 Tablets – The composition of Linagliptin Tablets 5mg is a DPP-4 (Dipeptidyl Peptidase-4) inhibitor. It works by inhibiting the DPP-4 enzyme, which normally breaks down incretin hormones such as GLP-1 (Glucagon-Like Peptide-1) and GIP (Gastric Inhibitory Polypeptide) which help to increased insulin secretion to stimulate the pancreas to release more insulin in response to meals, particularly when blood sugar levels are elevated and decreased glucagon secretion is a hormone that signals the liver to produce glucose. By inhibiting glucagon release, Linagliptin reduces the amount of glucose produced by the liver.

Key Benefits of Linagliptin Tablets 5MG – Laglin 5 Tablets
Low Risk of Hypoglycemia: Linagliptin does not typically cause low blood sugar (hypoglycemia) when used alone, providing a safer option for many patients, especially when compared to other glucose-lowering medication.
Effective Glycemic Control: It works through DPP-4 inhibition, enhancing the body’s natural insulin production and reducing liver glucose production, effectively lowering blood sugar levels in type 2 diabetes.
Flexible for Combination Therapy: Used alone or in combination with other diabetes medications (like metformin, insulin, or SGLT-2 inhibitors) for enhanced blood sugar control.

Recommended By Specalists:
Internal Medicine Specialists – For multimorbidity patients, Linagliptin is often used to manage type 2 diabetes alongside other health conditions.
Diabetologists – To Specialize in the treatment of diabetes, they frequently prescribe Linagliptin, especially in combination with other medications for blood sugar control.
Endocrinologists – For managing type 2 diabetes, especially in patients who need oral medication for glycemic control and may benefit from the DPP-4 inhibitor class.

INDICATIONS:
Type 2 Diabetes Mellitus (T2DM)
Patients with Renal Impairment
Adjunct to Diet and Exercise